Published in JAMA on October 22, 1982
Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract (2014) 1.45
Adverse reactions to the non-drug constituents of nebuliser solutions. Br J Clin Pharmacol (1988) 1.33
Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol (1990) 1.33
Adverse reactions to sulfites. CMAJ (1985) 1.02
Adverse reactions to the sulphite additives. Gastroenterol Hepatol Bed Bench (2012) 0.81
Considerations for the diagnosis and management of sulphite sensitivity. Gastroenterol Hepatol Bed Bench (2012) 0.75
Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet (2000) 4.19
Superantigens and their potential role in human disease. Adv Immunol (1993) 3.88
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest (1994) 2.88
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation (1994) 2.80
The revised two-factor Study Process Questionnaire: R-SPQ-2F. Br J Educ Psychol (2001) 2.72
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med (1997) 2.64
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography. Ann Intern Med (1997) 2.38
Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol (1992) 2.29
Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science (1976) 2.17
Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol (1993) 2.09
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet (1994) 2.00
Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest (1994) 1.98
Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J Exp Med (1988) 1.97
Onset and persistence of childhood asthma: predictors from infancy. Pediatrics (2001) 1.91
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol (1998) 1.87
Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest (1986) 1.81
Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun (2001) 1.80
Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol (1971) 1.76
Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol (1997) 1.75
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol (1994) 1.70
Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy (2010) 1.70
Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol (1991) 1.65
Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol (1999) 1.62
Production of IgE-potentiating factor in man by T cell lines bearing Fc receptors for IgE. Eur J Immunol (1984) 1.59
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med (1997) 1.58
Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol (2000) 1.56
Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J (1997) 1.53
Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol (1994) 1.52
Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol (1996) 1.52
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Localization of antigenic determinants in the polypeptide chains of collagen. Science (1969) 1.51
Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol (1998) 1.50
In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol (1996) 1.48
Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med (1998) 1.47
Induction of human IgE synthesis by a factor derived from T cells of patients with hyper-IgE states. J Immunol (1983) 1.46
Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol (1983) 1.46
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest (1987) 1.45
Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol (1996) 1.43
Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med (1999) 1.43
Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest (1990) 1.42
Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med (1990) 1.41
High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med (2001) 1.39
Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids. Pediatr Pulmonol (1994) 1.38
Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol (1992) 1.36
Differential requirements of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T cell clone. J Exp Med (1985) 1.35
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr (1986) 1.34
Metropolitan home living conditions associated with indoor endotoxin levels. J Allergy Clin Immunol (2001) 1.33
Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol (1995) 1.33
Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol (1983) 1.31
Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J Immunol (1994) 1.25
Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol (1982) 1.24
Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol (1996) 1.23
Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature (1986) 1.21
GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy (1998) 1.20
Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol (2001) 1.19
Enumeration of T cell subsets in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol (1981) 1.17
Is there a role for glucocorticoid receptor beta in glucocorticoid-dependent asthmatics? Am J Respir Crit Care Med (2000) 1.17
Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol (2001) 1.13
Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol (1997) 1.12
Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol (1992) 1.11
Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol (1996) 1.11
Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol (2000) 1.10
Induction of IgE synthesis in normal human B cells. Sequential requirements for activation by an alloreactive T cell clone and IgE-potentiating factors. J Exp Med (1986) 1.10
Role of macrophages in would healing. Surg Forum (1976) 1.09
Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation. J Allergy Clin Immunol (1980) 1.09
Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy (1986) 1.09
Molecular structure of staphylococcus and streptococcus superantigens. J Clin Immunol (1995) 1.08
Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am J Respir Crit Care Med (1997) 1.06
Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol (2000) 1.06
Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart (2005) 1.05
Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol (2000) 1.03
Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J (1988) 1.03
Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells. J Immunol (1985) 1.02
Evidence for superantigen production by Yersinia pseudotuberculosis. J Immunol (1993) 1.02
Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol (1998) 1.01
Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect Immun (2001) 1.01
Induction of IgG and IgE synthesis in normal B cells by autoreactive T cell clones. J Immunol (1986) 1.00
The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol (1995) 1.00
Histaminase release from human granulocytes. J Exp Med (1976) 1.00
Hyper immunoglobulin E syndrome. Immunodefic Rev (1989) 0.99
The role of glucocorticoids in the management of asthma. Allergy Asthma Proc (1997) 0.99
The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitis. Clin Immunol Immunopathol (1987) 0.99
Milk-sensitive and eosinophilic gastroenteropathy: similar clinical features with contrasting mechanisms and clinical course. J Allergy Clin Immunol (1984) 0.98
Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol (1998) 0.98
Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol Lett (2000) 0.98
Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol (2000) 0.98
Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol (1995) 0.98
Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest (1995) 0.98
Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol (2001) 0.97
Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol (1993) 0.97
Cell-mediated cytotoxicity against skin fibroblasts in atopic dermatitis. J Immunol (1982) 0.97
A new in vitro system for studying cell response to mechanical stimulation. Different effects of cyclic stretching and agitation on smooth muscle cell biosynthesis. Exp Cell Res (1977) 0.97
Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol (1992) 0.97
Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest (1995) 0.97
The production of thyroid autoantibodies in mice. J Immunol (1968) 0.96
Chronic urticaria in childhood: natural course and etiology. Ann Allergy (1983) 0.96
The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc (2001) 0.96